Specific immunotherapy added to pharmacologic treatment as a tool for working relocation in baker‘s occupational asthma

A. M. Cirla, P. E. Cirla (Cremona, Italy)

Source: Annual Congress 2009 - High molecular sensitisers and biological dusts
Session: High molecular sensitisers and biological dusts
Session type: Thematic Poster Session
Number: 1030
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. M. Cirla, P. E. Cirla (Cremona, Italy). Specific immunotherapy added to pharmacologic treatment as a tool for working relocation in baker‘s occupational asthma. Eur Respir J 2009; 34: Suppl. 53, 1030

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002

Specific inhalation challenge in the diagnosis of occupational asthma
Source: Guideline 2014
Year: 2014

Treatment of asthma above and beyond anti IgE: an update for the clinician The use of biologicals in asthma treatment
Source: International Congress 2018 – Difficult paediatric lung disease
Year: 2018


Is the specific inhalation challenge always needed for the diagnosis of occupational asthma? A pilot study
Source: Annual Congress 2009 - Occupational exposures and disease I
Year: 2009

Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy?
Source: Eur Respir J 2006; 28: Suppl. 50, 319s
Year: 2006

Anti-IgE treatment: An alternative for severe allergic occupational asthma
Source: Annual Congress 2012 - Asthma and COPD at work: what are the effects of exposure and risk factors?
Year: 2012


Are workplace specific inhalation challenges useful for the diagnosis of occupational asthma when challenges are negative in a hospital laboratory?
Source: Eur Respir J 2006; 28: Suppl. 50, 246s
Year: 2006

Effectiveness of pharmacist intervention for asthma control improvement
Source: Eur Respir J 2008; 31: 790-799
Year: 2008



The prevention of occupational asthma
Source: Eur Respir J 2003; 22: 853-860
Year: 2003



Specific immunotherapy in the management of allergic asthma
Source: Annual Congress 2008 - PG2 - Asthma: natural history, risk factors and overall management
Year: 2008



What is the optimal management option for occupational asthma?
Source: Eur Respir Rev 2012; 21: 97-104
Year: 2012



From guidelines to personalized treatment of children with asthma
Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents?
Year: 2020


Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006



The role of the individual rehabilitation programs in the complex treatment of the patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 519s
Year: 2004

A pragmatic guide to choosing biologic therapies in severe asthma
Source: Breathe, 17 (4) 210144; 10.1183/20734735.0144-2021
Year: 2021



Workplace-specific challenges as a contribution to the diagnosis of occupational asthma
Source: Eur Respir J 2008; 32: 997-1003
Year: 2008



Short-term effects of an educational intervention on airway inflammation in farmers with occupational asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 690s
Year: 2006

Rhinophototherapy: a new tool for the treatment of allergic rhinitis?
Source: ISSN=ISSN 1810-6838, ISBN=, page=174
Year: 2005

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012